Effectiveness of Image-Guided Radiotherapy in Adjuvant Radiotherapy on Survival for Localized Breast Cancer: A Population-Based Analysis

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network. Guidelines for breast cancer, version 6; 2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf. [free registration required]. Accessed 1128, 2020.
   Google Scholar
• Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106.16360786
   PubMed Web of Science ®Google Scholar
• Leonardi MC, Ricotti R, Dicuonzo S, et al. From technological advances to biological understanding: the main steps toward high-precision RT in breast cancer. Breast. 2016;29:213–222. doi:10.1016/j.breast.2016.07.01027542556
   PubMed Web of Science ®Google Scholar
• Bujold A, Craig T, Jaffray D, Dawson LA. Image-guided radiotherapy: has it influenced patient outcomes? Semin Radiat Oncol. 2012;22:50–61. doi:10.1016/j.semradonc.2011.09.00122177878
   PubMed Web of Science ®Google Scholar
• Simpson DR, Mell LK, Mundt AJ, et al. Image guided radiation therapy. In: Halperin EC, Wazer DE, Perez CA, Brady LW, editors. Perez & Brady’s Principles and Practice of Radiation Oncology, 7th ed. Philadelphia: Wolters Kluwer; 2018:288–307.
   Google Scholar
• Ghadjar P, Fiorino C, Munck Af Rosenschöld P, et al. ESTRO ACROP consensus guideline on the use of image guided radiation therapy for localized prostate cancer. Radiother Oncol. 2019;141:5–13. doi:10.1016/j.radonc.2019.08.02731668515
   PubMed Web of Science ®Google Scholar
• de Crevoisier R, Bayar MA, Pommier P, et al. Daily versus weekly prostate cancer image guided radiation therapy: phase 3 multicenter randomized trial. Int J Radiat Oncol Biol Phys. 2018;102:1420–1429. doi:10.1016/j.ijrobp.2018.07.200630071296
   PubMed Web of Science ®Google Scholar
• Chou SH, Li YH, Juan CJ, Juan CJ, Li CC, Chien CR. The effect of image-guided radiotherapy on cancer patients’ survival. Value Health Reg Issues. 2020;22(Supp):S4. doi:10.1016/j.vhri.2020.07.052
   Google Scholar
• Chiang CJ, Wang YW, Lee WC. Taiwan’s nationwide cancer registry system of 40 years: past, present, and future. J Formos Med Assoc. 2019;118:856–858. doi:10.1016/j.jfma.2019.01.01230773272
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453–1457. doi:10.1016/S0140-6736(07)61602-X18064739
   PubMed Web of Science ®Google Scholar
• Brunt AM, Haviland JS, Wheatley DA, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613–1626. doi:10.1016/S0140-6736(20)30932-632580883
   PubMed Web of Science ®Google Scholar
• Ali MS, Groenwold RH, Belitser SV, et al. Reporting of covariate selection and balance assessment in propensity score analysis is suboptimal: a systematic review. J Clin Epidemiol. 2015;68:112–121. doi:10.1016/j.jclinepi.2014.08.01125433444
   PubMed Web of Science ®Google Scholar
• Liang JA, Tu CY, Hsia TC, Fang HY, Li CC, Chien CR. Effectiveness of image-guided radiotherapy for locally advanced lung cancer patients treated with definitive concurrent chemoradiotherapy. Thorac Cancer. 2020;11:2639–2649. doi:10.1111/1759-7714.1359632725779
   PubMed Web of Science ®Google Scholar
• Kuo YH, Fang HY, Lin YS, et al. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy. Thorac Cancer. 2020;11:113–119. doi:10.1111/1759-7714.1324431742897
   PubMed Web of Science ®Google Scholar
• Lalani N, Jimenez RB, Yeap B. Understanding propensity score analyses. Int J Radiat Oncol Biol Phys. 2020;107:404–407. doi:10.1016/j.ijrobp.2020.02.63832531385
   PubMed Web of Science ®Google Scholar
• Rosenbaum PR. Chapter 5 between observational studies and experiments. In: Rosenbaum PR, editor. Observation and Experiment. Cambridge, Massachusetts: Harvard University Press; 2017.
   Google Scholar
• Booth CM, Karim S, Mackillop WJ. Real-world data: towards achieving the achievable in cancer care. Nat Rev Clin Oncol. 2019;16:312–325. doi:10.1038/s41571-019-0167-730700859
   PubMed Web of Science ®Google Scholar
• Garrido MM, Kelley AS, Paris J, et al. Methods for constructing and assessing propensity scores. Health Serv Res. 2014;49:1701–1720. doi:10.1111/1475-6773.1218224779867
   PubMed Web of Science ®Google Scholar
• Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med. 2014;33:1242–1258. doi:10.1002/sim.598424122911
   PubMed Web of Science ®Google Scholar
• Mao H, Li L, Greene T. Propensity score weighting analysis and treatment effect discovery. Stat Methods Med Res. 2019;28:2439–2454. doi:10.1177/096228021878117129921162
   PubMed Web of Science ®Google Scholar
• Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed. 2004;75:45–49. doi:10.1016/j.cmpb.2003.10.00415158046
   PubMed Web of Science ®Google Scholar
• Austin PC. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis. Stat Med. 2016;35:5642–5655. doi:10.1002/sim.708427549016
   PubMed Web of Science ®Google Scholar
• Bolch CA, Chu H, Jarosek S, Cole SR, Elliott S, Virnig B. Inverse probability of treatment-weighted competing risks analysis: an application on long-term risk of urinary adverse events after prostate cancer treatments. BMC Med Res Methodol. 2017;17:93. doi:10.1186/s12874-017-0367-828693428
   PubMed Web of Science ®Google Scholar
• Loganadane G, Truong PT, Taghian AG, et al. Comparison of nodal target volume definition in breast cancer radiation therapy according to RTOG versus ESTRO atlases: a practical review from the TransAtlantic Radiation Oncology Network (TRONE). Int J Radiat Oncol Biol Phys. 2020;107:437–448. doi:10.1016/j.ijrobp.2020.04.01232334035
   PubMed Web of Science ®Google Scholar
• Breast cancer atlas for Radiation Therapy Planning: Consensus Definitions. Available from: https://www.nrgoncology.org/Portals/0/Scientific%20Program/CIRO/Atlases/BreastCancerAtlas_corr.pdf?ver=2018-04-18-144201-270&ver=2018-04-18-144201-270. Accessed April 1st, 2021.
   Google Scholar
• Lan XW, Wen G, He Z, et al. Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer. Cancer Manag Res. 2019;11:6477–6487. doi:10.2147/CMAR.S20963431372049
   PubMed Web of Science ®Google Scholar
• Bartelink H. Radiotherapy to the conserved breast, chest wall, and regional nodes: is there a standard? Breast. 2003;12:475–482. doi:10.1016/S0960-9776(03)00155-314659124
   PubMed Web of Science ®Google Scholar
• Edwards-Bennett SM, Correa CR, Harris EE. Optimization of adjuvant radiation in breast conservation therapy: can we minimize without compromise? Int J Breast Cancer. 2011;2011:321304. doi:10.4061/2011/32130422295217
   PubMedGoogle Scholar
• Yang DS, Yoon WS, Chung SY, et al. Set-up uncertainty during breast radiotherapy. Image-guided radiotherapy for patients with initial extensive variation. Strahlenther Onkol. 2013;189:315–320. doi:10.1007/s00066-012-0271-423443609
   PubMed Web of Science ®Google Scholar
• Mészáros N, Major T, Stelczer G, et al. Implementation of image-guided intensity-modulated accelerated partial breast irradiation: three-year results of a Phase II clinical study. Strahlenther Onkol. 2017;193:70–79. doi:10.1007/s00066-016-1074-927872946
   PubMed Web of Science ®Google Scholar
• Bergom C, Prior P, Kainz K, et al. A phase I/II study piloting accelerated partial breast irradiation using CT-guided intensity modulated radiation therapy in the prone position. Radiother Oncol. 2013;108:215–219. doi:10.1016/j.radonc.2013.05.03923932158
   PubMed Web of Science ®Google Scholar
• Armenian SH, Lacchetti C, Barac A, et al. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017;35:893–911. doi:10.1200/JCO.2016.70.540027918725
   PubMed Web of Science ®Google Scholar
• Jin F, Luo HL, Zhou J, et al. Cancer risk assessment in modern radiotherapy workflow with medical big data. Cancer Manag Res. 2018;10:1665–1675. doi:10.2147/CMAR.S16498029970965
   PubMedGoogle Scholar
• Johansson S, Svensson H, Denekamp J. Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2002;52:1207–1219. doi:10.1016/S0360-3016(01)02743-211955731
   PubMed Web of Science ®Google Scholar